International team acts for Bausch Health Companies Inc. in a US$2bn cross-border senior notes financing
Canada | December 16, 2020
Client: Bausch Health Companies Inc.
Our Montreal, Moscow and London offices acted as counsel to Bausch Health Companies Inc., as issuer, in connection with its cross-border private placement of US$2bn (US$1bn aggregate principal amount of its new 5.000% senior notes due 2029 and US$1bn aggregate principal amount of its new 5.250% senior notes due 2031).
The proceeds of the notes offering, along with cash on hand, were used to redeem US$1.758m aggregate principal amount of the company’s outstanding 4.500% senior notes due 2023 and US$233m aggregate principal amount of the company’s outstanding 5.500% senior notes due 2023, and to pay related fees and expenses.
The team was led by Peter Wiazowski and included Thomas Nichols, Dan Ton-That and Audrey Levesque (Montreal), Aleksander Tsakoev and Yevgenia Belokon (Moscow) and Tomas Gardfors and Yens Nessow (London). Derek Chiasson advised regarding Canadian tax matters.